Commonwealth Equity Services’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Commonwealth Equity Services’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-646,000	Closed	-$142K	–	3989
2023 Q2	$142K	Hold	646,000	–	–	﹤0.01%	3506
2023 Q1	$202	Buy	646,000 +71,000	+12%	+$51.5K	﹤0.01%	3314
2022 Q4	$678K	Buy	575,000 +7,800	+1%	+$7.53K	﹤0.01%	2225
2022 Q3	$527K	Hold	567,200	–	–	﹤0.01%	2365
2022 Q2	$623K	Sell	567,200 -10,000	-2%	-$12.4K	﹤0.01%	2250
2022 Q1	$1.01M	Buy	577,200 +557,000	+2,757%	+$1.05M	﹤0.01%	1984
2021 Q4	$47K	Buy	+20,200	New	+$57.5K	﹤0.01%	3542

Other funds holding ARDS

Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Commonwealth Equity Services's ARDS Position: Q3 2023 in Review

Commonwealth Equity Services sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 646,000 shares — an estimated $142K sold.

Commonwealth Equity Services first reported a position in ARDS in Q4 2021 and held it in 7 quarters. The position peaked at $1.01M in Q1 2022. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

Commonwealth Equity Services reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Commonwealth Equity Services sold 646,000 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $142K.
Commonwealth Equity Services first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Commonwealth Equity Services's Aridis Pharmaceuticals Inc. Common Stock position peaked at $1.01M in Q1 2022.
1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.